Prenatal DNA test patent invalid, U.S. appeals court says

NEW YORK, June 12 (Reuters) - A U.S. appeals court on Friday said a Sequenom Inc patent on a prenatal test to detect fetal DNA is invalid because it relates to a natural phenomenon, which cannot be patented according to U.S. Supreme Court precedent.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.